Clinical Trial Details
— Status: Not yet recruiting
Administrative data
NCT number |
NCT05140161 |
Other study ID # |
1206-N-15 |
Secondary ID |
|
Status |
Not yet recruiting |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
December 20, 2021 |
Est. completion date |
February 21, 2022 |
Study information
Verified date |
November 2021 |
Source |
University of Seville |
Contact |
ANTONIO CÓRDOBA FERNÁNDEZ, PHD |
Phone |
+34 685860512 |
Email |
acordoba[@]us.es |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
The objective of this study is to evaluate the hemostatic capacity of two types of collagen
hemostatic sponges in nail surgery.
It is a randomized triple-blind clinical trial with two experimental groups (medium porosity
collagen and high porosity collagen) and control group ( non collagen).
Description:
To evaluate bleeding, all patients with onychocryptosis will be operated on with the same
technique.
In the experimental groups, once the surgical procedure has been completed on both edges of
the nail, hemostatic collagen will be applied in the experimental groups (experimental group
1- medium porosity collagen and experimental group 2-high porosity collagen) In all groups,
including the control, once the intervention was finished, the same bandage was performed
with the same number of gauze pads.
At 72 hours, the gauze set will be removed to weigh it using a precision balance and
quantitatively evaluate the amount of bleeding.
In this way, a comparative study can be carried out between the 3 groups and determine if
there are statistically significant differences or not, and can determine if lyophilized
hemostatic collagen is useful in nail surgery and if there are significant differences
between both experimental groups, determining if the percentage of porosity in a hemostatic
is relevant in the hemostatic effect.